In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines

被引：0
|
作者：
Ioannis A. Avramis
Garyfallia Christodoulopoulos
Atsushi Suzuki
Walter E. Laug
Ignacio Gonzalez-Gomez
George McNamara
Edward A. Sausville
Vassilios I. Avramis
机构：
[1] Division of Hematology/Oncology,
[2] Department of Pediatrics,undefined
[3] Childrens Hospital Los Angeles,undefined
[4] USC Keck School of Medicine,undefined
[5] 4650 Sunset Blvd,undefined
[6] Los Angeles,undefined
[7] CA 90027,undefined
[8] USA,undefined
[9] Department of Pathology,undefined
[10] Childrens Hospital Los Angeles,undefined
[11] USC Keck School of Medicine,undefined
[12] Los Angeles,undefined
[13] CA,undefined
[14] USA,undefined
[15] National Cancer Institute,undefined
[16] Rockville,undefined
[17] MD,undefined
[18] USA,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2002年 / 50卷
关键词：
Tyrosine kinase Leukemia Brain tumors Apoptosis VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract
引用
收藏
页码：479 / 489
页数：10
相关论文
共 50 条
  • [21] Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways
    Tang, Carine
    Schafranek, Lisa
    Watkins, Dale B.
    Parker, Wendy T.
    Moore, Sarah
    Prime, Jodi A.
    White, Deborah L.
    Hughes, Timothy P.
    LEUKEMIA & LYMPHOMA, 2011, 52 (11) : 2139 - 2147
  • [22] The cytotoxicity of methyl protoneodioscin (NSC-698791) against human cancer cell lines in vitro
    Hu, K
    Yao, XS
    ANTICANCER RESEARCH, 2002, 22 (2A) : 1001 - 1005
  • [23] TKI258, a Multi-tyrosine Kinase Inhibitor Is Efficacious Against Human Infant/Childhood Lymphoblastic Leukemia In Vitro
    Eucker, Jan
    Zang, Chuanbing
    Zhou, Yongan
    Li, Xinhua
    Habbel, Piet
    Schulz, Carsten-Oliver
    Scholz, Christian
    Liu, Hongyu
    ANTICANCER RESEARCH, 2014, 34 (09) : 4899 - 4907
  • [24] Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo
    Deng, Lin
    Li, Gang
    Li, Ronghui
    Liu, Qinglin
    He, Qiaowei
    Zhang, Jian
    CANCER BIOLOGY & THERAPY, 2010, 9 (11) : 875 - 884
  • [25] Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib
    Ott, Ingo
    Abraham, Angelika
    Schumacher, Petra
    Shorafa, Hashem
    Gastl, Guenther
    Gust, Ronald
    Kircher, Brigitte
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2006, 100 (11) : 1903 - 1906
  • [26] In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines
    Ferruzzi, Pietro
    Mennillo, Federica
    De Rosa, Antonella
    Giordano, Cinzia
    Rossi, Marco
    Benedetti, Giovanni
    Magrini, Roberta
    Mohr, Galla Pericot
    Miragliotta, Vincenzo
    Magnoni, Letizia
    Mori, Elisa
    Thomas, Russell
    Tunici, Patrizia
    Bakker, Annette
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (02) : E33 - E44
  • [27] In vitro and in vivo characterization of a potent tyrosine kinase inhibitor that modulates angiogenesis and cancer cell proliferation
    Heise, C
    Wiesmann, M
    Vora, J
    Lee, S
    Renhowe, P
    Harrison, S
    Samara, E
    Hibner, B
    Harris, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S61 - S62
  • [28] Differential response of glioblastoma cell lines to the tyrosine kinase and angiogenic inhibitor sunitinib malate based on their MGMT status
    Chahal, Manik
    Sabri, Siham
    Xu, Yaoxian
    Lesniak, David
    Jacques, Amanda
    Graham, Kathryn
    Abdulkarim, Bassam
    CANCER RESEARCH, 2009, 69
  • [29] The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
    Ponader, Sabine
    Chen, Shih-Shih
    Buggy, Joseph J.
    Balakrishnan, Kumudha
    Gandhi, Varsha
    Wierda, William G.
    Keating, Michael J.
    O'Brien, Susan
    Chiorazzi, Nicholas
    Burger, Jan A.
    BLOOD, 2012, 119 (05) : 1182 - 1189
  • [30] Expression of TIE receptor tyrosine kinase in human leukemia-lymphoma cell lines.
    Bredoux, CM
    Uphoff, CC
    Drexler, HG
    BLOOD, 1996, 88 (10) : 1486 - 1486
12345